While medical innovation is accelerating, access to essential healthcare remains out of reach for over 2 billion people. Especially in countries with constrained healthcare infrastructure, where nearly 80% of the global population lives. Treatments long available in wealthier nations are still inaccessible elsewhere due to cost, infrastructure, and policy barriers. Meanwhile, the cost of medical technology continues to rise, with global healthcare spending projected to grow by over 10% annually. This threatens to widen the gap between innovation and accessibility.

Patrick, managing director: "We are committed to closing that gap. There’s no need to reinvent the wheel for every respiratory device. By offering flexible, modular ventilator platforms and reducing redundant development time, we help our partners focus on what truly matters: developing effective treatments in an affordable, high-quality respiratory care environment."

Our mission is clear: accelerating respiratory innovation.
We aim to drive access to critical care in regions with limited healthcare access while unlocking higher standards of respiratory technology for the rest of the world. Efficiently, affordably, and without compromise.